Grupo Espanol De Tumores Neuroendocrinos

This study tested whether adding the drug axitinib to standard sandostatin therapy could slow cancer growth in people with advanced neuroendocrine tumors (a type of slow-growing cancer). The trial involved 256 adults whose cancer had worsened in the past year. Researchers measure…

This study looked at how well the drug cabozantinib works in people with advanced thyroid cancer that no longer responds to radioactive iodine treatment. It involved 41 adults and focused on finding genetic markers in the blood that might predict how the cancer responds. The goal…

This study looked back at medical records of 19 Spanish patients with various cancers that have a specific genetic change called an NTRK fusion. All patients received the drug larotrectinib through a special access program before it was widely available. The goal was to see how w…